US2012196816A1PendingUtilityA1
Method for enhancing nutrient absorption with astragalosides
Est. expiryJun 23, 2025(expired)· nominal 20-yr term from priority
A61P 3/02A61P 3/00A61P 1/00A61K 36/481A61K 31/704
48
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present application relates to a method for enhancing absorption of a nutrient in a subject in need thereof with an effective amount of an isolated astragaloside compound.
Claims
exact text as granted — not AI-modified1 - 27 . (canceled)
28 . A method for enhancing absorption of folate in a subject in need thereof, comprising:
identifying a human subject in need of enhanced absorption of folate, and administering to the subject an effective amount of an isolated astragaloside compound for facilitating transportation of folate across gut cells of the subject, wherein the subject is an elderly, a pregnant woman, a nursing mother, or a patient having insomnia, depression, a cardiovascular disease, or long-term pressure.
29 . The method of claim 28 , wherein the astragaloside compound is an astragaloside compound of Formula (A):
wherein R 1 is selected from the group consisting of H, OH, O-acetyl, O-xylopyranosyl, O-(2-acetylxylopyranosyl), O-(3-acetylxylopyranosyl), O-(2,3-diacetylxylopyranosyl), O-(2,4-diacetylxylopyranosyl), O-xylopyranosyl-(1-2)-β-D-glucopyranosyl, and O-xylopyranosyl-(1-2)-α-arabinopyranosyl; R 2 is selected from the group consisting of H, OH, O-acetyl, O-glucopyranosyl, and O-xylopyranosyl; R 3 is selected from the group consisting of H, OH, and O-acetyl; and R 4 is selected from the group consisting of
30 . The method of claim 29 , wherein the astragaloside compound is selected from the group consisting of astragaloside I of Formula I:
astragaloside II of Formula II:
astragaloside III of Formula III:
astragaloside IV of Formula IV:
isoastragaloside I of Formula V:
astragaloside VI of Formula VI:
isoastragaloside II of Formula VII:
cycloastragenol-6-O-β-D-glucopyranose of Formula VIIICited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.